Summary
- Current Price
- As of today, URGN price is $18.59, up +0.60% on
- Current Price All-Time High
- URGN price is currently -73.28% below its historical high of $69.57 set on
- Market Cap
- URGN current market cap is $870M, up +61.91% over the past 365 days
- PE Ratio
- URGN PE ratio is unknown
- Revenue
- URGN current annual revenue is $109.79M, up +21.45% year-over-year
- Next Earnings
- The next earnings release for URGN is on
Profile
| Metric | Value |
|---|---|
| Full Name | UroGen Pharma Ltd. |
| Ticker | NASDAQ: URGN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | urogen.com |
| Employees | 234 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $18.59 | |
| Price, 1D Change | +0.60% | |
| $870M | ||
| - | ||
| - | ||
| 1.12 | ||
| $110M | ||
| Revenue, 1Y Change | +21.45% | |
| -$3.19 | ||
| EPS, 1Y Change | -7.81% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.19 | ||
| EPS Estimate | N/A | -$1.17 |
| EPS Est. Change | N/A | +63.44% |
| $109.79M | ||
| Revenue Estimate | N/A | $244.52M |
| Revenue Est. Change | N/A | +122.72% |
| Current Price | $18.59 | |
| Price Target | - | $34.50 |
| Price Tgt. Change | - | +85.58% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.13 | -$2.96 | +5.38% | |
| -$3.15 | -$3.19 | -1.32% | |
| -$1.17 | N/A | +63.44% | |
| $0.92 | N/A | +128.92% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $91.00M | $90.40M | -0.66% | |
| $111.87M | $109.79M | -1.86% | |
| $244.52M | N/A | +122.72% | |
| $425.02M | N/A | +287.13% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $18.59 | |
| $19.13 | ||
| SMA 200 vs Price | +2.90% | |
| $20.31 | ||
| SMA 50 vs Price | +9.25% | |
| 1.12 | ||
| $1.34 | ||
| 40.98 | ||
| 35.83% | ||
| 113.82% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $109.79M | ||
| -$3.19 | ||
| $97.34M | ||
| 88.66% | ||
| -$124.86M | ||
| -113.73% | ||
| -$153.49M | ||
| -139.81% | ||
| -$122.45M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -1.23 | ||
| 4.01 | ||
| 3.65 | ||
| - | ||
| 2 | ||
| -5.67 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 7.93 | ||
| -8.25 | ||
| -7.17 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$105.47M | ||
| $121.81M | ||
| $200.46M | ||
| $186.02M | ||
| $305.93M | ||
| $46.42M | ||
| $130.09M | ||
| $1.76M | ||
| $12.14M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $263.28M | ||
| $222.20M | ||
| $12.45M | ||
| $0.00 | ||
| $2.41M | ||
| $0.00 | ||
| $78.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$162.44M | ||
| $61.56M | ||
| $39.92M | ||
| $289.00K | ||
| -$162.73M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| HC Wainwright & Co. | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| Piper Sandler | ||
| HC Wainwright & Co. | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → |
Analyst sentiment
Institutional ownership
Screeners with URGN
FAQ
What is the ticker symbol for UroGen Pharma Ltd.?
The ticker symbol for UroGen Pharma Ltd. is NASDAQ:URGN
Does UroGen Pharma Ltd. pay dividends?
No, UroGen Pharma Ltd. does not pay dividends
What sector is UroGen Pharma Ltd. in?
UroGen Pharma Ltd. is in the Healthcare sector
What industry is UroGen Pharma Ltd. in?
UroGen Pharma Ltd. is in the Biotechnology industry
What country is UroGen Pharma Ltd. based in?
UroGen Pharma Ltd. is headquartered in United States
When did UroGen Pharma Ltd. go public?
UroGen Pharma Ltd. initial public offering (IPO) was on May 4, 2017
Is UroGen Pharma Ltd. in the S&P 500?
No, UroGen Pharma Ltd. is not included in the S&P 500 index
Is UroGen Pharma Ltd. in the NASDAQ 100?
No, UroGen Pharma Ltd. is not included in the NASDAQ 100 index
Is UroGen Pharma Ltd. in the Dow Jones?
No, UroGen Pharma Ltd. is not included in the Dow Jones index
When was UroGen Pharma Ltd. last earnings report?
UroGen Pharma Ltd.'s most recent earnings report was on March 2, 2026
When does UroGen Pharma Ltd. report earnings?
The next expected earnings date for UroGen Pharma Ltd. is May 12, 2026
Data Sources & References
- URGN Official Website www.urogen.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1668243/000143774926006234/0001437749-26-006234-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1668243/000143774926006234/0001437749-26-006234-index.htm
- URGN Profile on Yahoo Finance finance.yahoo.com/quote/URGN
- URGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/urgn